» Articles » PMID: 34519099

Participant Experiences in the Diabetes REmission Clinical Trial (DiRECT)

Overview
Journal Diabet Med
Specialty Endocrinology
Date 2021 Sep 14
PMID 34519099
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The Diabetes REmission Clinical Trial (DiRECT) has shown that sustained remission of type 2 diabetes in primary care is achievable through weight loss using total diet replacement (TDR) with continued behavioural support. Understanding participants' experiences can help optimise the intervention, support implementation into healthcare, and understand the process of behaviour change.

Methods: Thirty-four DiRECT participants were recruited into this embedded qualitative evaluation study. In-person and telephone interviews were conducted before the TDR; at week 6-8 of the TDR; 2 weeks into food reintroduction (FR); and at 1 year, to learn about participant experiences with the programme. Transcribed narratives were analysed thematically, and we used interpretation to develop overarching themes.

Results: Initiation of the TDR and transition to FR were challenging and required increased behavioural support. In general, adhering to TDR proved easier than the participants had anticipated. Some participants chose the optional extension of TDR. Rapid weight loss and changes in diabetes markers provided ongoing motivation. Further weight loss, behavioural support and occasional use of TDR facilitated weight loss maintenance (WLM). A process of behaviour adaptation to change following regime disruption was identified in three stages: (1) expectations of the new, (2) overcoming difficulties with adherence, and (3) acceptance of continuous effort and establishment of routines.

Conclusions: The DiRECT intervention was acceptable and regularity, continuity, and tailoring of behavioural support was instrumental in its implementation in primary care. The adaptation process accounts for some of the individual variability of experiences with the intervention and highlights the need for programme flexibility.

Citing Articles

Barriers and enablers to engagement with a type 2 diabetes remission project in the North East of England: qualitative perspectives of patients.

Boocock R, Haste A, Moore H, Lake A J Nutr Sci. 2025; 13():e28.

PMID: 39776522 PMC: 11704941. DOI: 10.1017/jns.2024.30.


Experiences and Acceptability of a Weight Loss Intervention for Diabetes (Diabetes Remission Clinical Trial-DiRECT) in Aotearoa New Zealand: A Qualitative Study within a Pilot Randomised Controlled Trial.

Campbell K, Peddie M, Ashton N, Maiai K, Russell-Camp T, Mann J Nutrients. 2024; 16(12).

PMID: 38931208 PMC: 11206426. DOI: 10.3390/nu16121853.


Experiences of living with overweight/obesity and early type 2 diabetes in Singapore-a qualitative interview study.

Lee M, Khoo H, Krishnasamy C, Loo M, Wong S, Cheng S BMJ Open. 2024; 14(5):e079082.

PMID: 38719302 PMC: 11086526. DOI: 10.1136/bmjopen-2023-079082.


Interprofessional follow-up for people at risk of type 2 diabetes in primary healthcare - a randomized controlled trial with embedded qualitative interviews.

Graue M, Igland J, Oftedal B, Haugstvedt A, Riise H, Zoffmann V Scand J Prim Health Care. 2024; 42(3):450-462.

PMID: 38588447 PMC: 11332301. DOI: 10.1080/02813432.2024.2337071.


Remission of type 2 diabetes: always more questions, but enough answers for action.

Rothberg A, Lean M, Laferrere B Diabetologia. 2024; 67(4):602-610.

PMID: 38189935 PMC: 10904507. DOI: 10.1007/s00125-023-06069-1.